• ქართული
  • English
  • France's Sanofi to buy Synthorx for $2.5 billion

    France’s Sanofi said on Monday it had agreed to buy Synthorx in a cash deal worth around $2.5 billion as it seeks to beef up its immuno-oncology pipeline.

    Market Quotes by TradingView